Genomic Profiling of Pediatric Solid Tumors With a Dual DNA / RNA Panel: JCCG‐TOP2 Study
Cancer Science · 2026-02 · 117 (2) · 522-535
DOI: 10.1111/cas.70249 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer Science, online erschienen am 17.11.2025. Verfasst von Kayoko Tao und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Health Research Promotion Bureau, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
To develop an optimized genomic medicine platform for pediatric cancers, a nationwide cancer genome profiling project was conducted from January 2022 to February 2023 in collaboration with the Japan Children's Cancer Group. This prospective observational study analyzed matched blood and FFPE tumor samples from patients aged 0–29 years with solid tumors. Genomic analysis used the TOP2 hybrid capture–enrichment system, targeting 737 and 455 genes in the DNA and RNA panels, along with allele‐specific genome copy number alterations. A total of 210 patients from 50 institutions were enrolled across Japan (median age, 8 years; range, 0–25). Of these, 154 (77%) were enrolled at diagnosis or during/after initial treatment and 56 (27%) at disease progression or relapse. The TOP2 findings had great benefits in clarifying the diagnosis of pediatric solid tumors. Among the 204 patients with genomic results, 147 (72%) had potentially actionable findings, including diagnostic, prognostic, and therapeutic findings in 111 (54%), 61 (30%), and 64 (31%), respectively. Oncogenic fusions were noted in 45 (23%) patients. A copy number alteration was identified in at least one genomic region in 170 (83%) patients. Two patients exhibited a high tumor mutation burden. Seventeen (8%) patients harbored a germline pathogenic/likely pathogenic variant in cancer‐predisposing genes. This study highlighted the feasibility of implementing a nationwide precision medicine platform and the clinical utility of the TOP2 system for pediatric cancers. The results support the integration of genomic data into the standard clinical care of pediatric patients with cancer, both at diagnosis and at relapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Cancer Center Hospital, Tokyo, Japan.
- Department of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
- Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
- Department of Pathology, National Center for Child Health and Development, Tokyo, Japan.
- Department of Childhood Cancer Data Management, National Center for Child Health and Development, Tokyo, Japan.
- Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
ORCID-Profile: Kayoko Tao, Miho Kato, Yoshiko Nakano, Yoshihiro Otani, Yasushi Yatabe, Kenichi Kohashi, Shinji Kohsaka, Kuniko Sunami, Koichi Ichimura
Förderung
- Japan Health Research Promotion Bureau
- Japan Agency for Medical Research and Development
Zitieren
APA
Tao, K., Yoshioka, T., Kato, M., Komatsu, K., Tsujimoto, S., Sakamoto, K., Tanimura, K., Sugiyama, M., Sekiguchi, M., Nakano, Y., Otani, Y., Yatabe, Y., Yoshida, A., Okita, H., Hirato, J., Kohashi, K., Tanaka, Y., Kohsaka, S., Kubo, T., …, & Kato, M. (2026). Genomic Profiling of Pediatric Solid Tumors With a Dual DNA / RNA Panel: JCCG‐TOP2 Study. Cancer Science, 117(2), 522-535. https://doi.org/10.1111/cas.70249
Vancouver
Tao K, Yoshioka T, Kato M, Komatsu K, Tsujimoto S, Sakamoto K, et al. Genomic Profiling of Pediatric Solid Tumors With a Dual DNA / RNA Panel: JCCG‐TOP2 Study. Cancer Science. 2026;117(2):522-535. doi:10.1111/cas.70249
BibTeX
@article{Tao2026,
author = {Tao, Kayoko and Yoshioka, Takako and Kato, Miho and Komatsu, Kazuyuki and Tsujimoto, Shinichi and Sakamoto, Kenichi and Tanimura, Kazuki and Sugiyama, Minako and Sekiguchi, Masahiro and Nakano, Yoshiko and Otani, Yoshihiro and Yatabe, Yasushi and Yoshida, Akihiko and Okita, Hajime and Hirato, Junko and Kohashi, Kenichi and Tanaka, Yukichi and Kohsaka, Shinji and Kubo, Takashi and Sunami, Kuniko and Hirata, Makoto and Tsutsumi, Shuichi and Aburatani, Hiroyuki and Koh, Katsuyoshi and Hirayama, Masahiro and Karakawa, Shuhei and Terashita, Yukayo and Fujisaki, Hiroyuki and Yagi, Takeshi and Yoneda, Akihiro and Mochizuki, Shinji and Shichino, Hiroyuki and Suzuki, Tatsuya and Takimoto, Tetsuya and Ichimura, Koichi and Ogawa, Chitose and Matsumoto, Kimikazu and Ichikawa, Hitoshi and Kato, Motohiro},
title = {Genomic Profiling of Pediatric Solid Tumors With a Dual DNA / RNA Panel: JCCG‐TOP2 Study},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {2},
pages = {522--535},
doi = {10.1111/cas.70249}
}
EUVIMED